Ruanjian Qingmai granules | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,359 results for “Ruanjian Qingmai granules”

Trials

View all 869 →

ITMCTR2023000056

Evaluation of the efficacy of Ruanjian Qingmai granules in the treatment of peripheral arterial disease after revascularizatio

Not yet recruiting

ITMCTR2200005580

A randomized controlled trial of Ruanjian Qingmai Granule in the treatment of peripheral arterial disease

Active, not recruiting

Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction

60 participants · First posted Apr 3, 2024

Drugs

View all 381 →

Xuechan Ruanjian Rougan Tablets

Qingyi granules

Huangjia Ruangan Granules

Organizations

View all 54 →

GRANULES INDIA

India

GRANULES INDIA LIMITED

India

Granules Pharmaceuticals, Inc.

United States

News

View all 55 →

Ruanjian Qingmai Granules Evaluated in Clinical Trial for Early Symptomatic Peripheral Artery Disease

Granules Pharmaceuticals Secures FDA Approval for Lisdexamfetamine Dimesylate Chewable Tablets

Granules Pharmaceuticals Receives Tentative FDA Approval for Generic ADHD Treatment

Page 1 of 136